A detailed history of Pnc Financial Services Group, Inc. transactions in Evogene Ltd. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 38,034 shares of EVGN stock, worth $95,085. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,034
Previous 38,034 -0.0%
Holding current value
$95,085
Previous $28,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$0.7 - $0.98 $11,023 - $15,433
15,748 Added 70.66%
38,034 $28,000
Q4 2023

Feb 09, 2024

SELL
$0.47 - $0.88 $6,445 - $12,068
-13,714 Reduced 38.09%
22,286 $18,000
Q3 2023

Nov 13, 2023

BUY
$0.58 - $1.41 $20,880 - $50,760
36,000 New
36,000 $21,000
Q3 2020

Nov 06, 2020

SELL
$0.97 - $4.08 $8,245 - $34,680
-8,500 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$0.92 - $1.29 $7,820 - $10,965
8,500 New
8,500 $8,000

Others Institutions Holding EVGN

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $103M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.